Ubs Group Ag Guardant Health, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 361,067 shares of GH stock, worth $17.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

361,067

Previous 60,444 497.36%

Holding current value

$17.2 Million

Previous $1.75 Million 374.44%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $6.7 Million - $10.9 Million	300,623 Added 497.36%	361,067 $8.28 Million
Q2 2024 Aug 13, 2024	SELL	$16.07 - $31.84 $1.12 Million - $2.22 Million	-69,813 Reduced 53.6%	60,444 $1.75 Million
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $358,599 - $563,333	-20,934 Reduced 13.85%	130,257 $2.69 Million
Q4 2023 Feb 09, 2024	BUY	$21.58 - $29.5 $1.46 Million - $1.99 Million	67,458 Added 80.56%	151,191 $4.09 Million
Q3 2023 Nov 09, 2023	SELL	$25.8 - $39.97 $714,531 - $1.11 Million	-27,695 Reduced 24.85%	83,733 $2.48 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $1.57 Million - $2.85 Million	74,953 Added 205.49%	111,428 $3.99 Million
Q1 2023 May 12, 2023	SELL	$22.92 - $33.76 $345,312 - $508,628	-15,066 Reduced 29.23%	36,475 $854,000
Q4 2022 Feb 08, 2023	BUY	$25.44 - $59.78 $1.01 Million - $2.36 Million	39,556 Added 330.05%	51,541 $1.4 Million
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $515,187 - $719,800	-11,800 Reduced 49.61%	11,985 $645,000
Q2 2022 Aug 10, 2022	SELL	$28.82 - $77.35 $656,490 - $1.76 Million	-22,779 Reduced 48.92%	23,785 $960,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $348,992 - $726,844	7,233 Added 18.39%	46,564 $3.08 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.13 Million - $1.54 Million	12,756 Added 48.0%	39,331 $3.93 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $24,001 - $32,117	243 Added 0.92%	26,575 $3.32 Million
Q2 2021 Aug 13, 2021	SELL	$109.77 - $165.68 $3.79 Million - $5.72 Million	-34,538 Reduced 56.74%	26,332 $3.27 Million
Q1 2021 May 12, 2021	BUY	$127.04 - $179.1 $1.12 Million - $1.58 Million	8,831 Added 16.97%	60,870 $9.29 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $1.63 Million - $2.22 Million	16,317 Added 45.68%	52,039 $6.71 Million
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $279,352 - $388,840	-3,478 Reduced 8.87%	35,722 $3.99 Million
Q2 2020 Jul 31, 2020	BUY	$60.49 - $97.5 $1.28 Million - $2.06 Million	21,170 Added 117.42%	39,200 $3.18 Million
Q1 2020 May 01, 2020	SELL	$59.04 - $88.81 $112,176 - $168,739	-1,900 Reduced 9.53%	18,030 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $154,019 - $214,317	2,589 Added 14.93%	19,930 $1.56 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $226,700 - $399,506	-3,622 Reduced 17.28%	17,341 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $664,336 - $946,632	10,390 Added 98.27%	20,963 $1.81 Million
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $223,841 - $639,417	6,526 Added 161.26%	10,573 $811,000
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $118,172 - $186,566	4,047 New	4,047 $152,000

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.87B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account